Medical AI Alliance
← Company Index
Biotech & Drug DiscoveryKOSPI 285130150 approvals59 trials

SK Chemicals Co., Ltd.

Official website

A diversified SK group company operating eco-friendly chemical materials alongside pharmaceutical products like Joins and vaccines through subsidiary SK Bioscience.

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2017 and listed on KOSPI in 2018, SK Chemicals operates both chemical materials and pharmaceutical/bio businesses. Its Green Chemicals Biz. produces eco-friendly Copolyester resins (SKYGREEN, ECOZEN, ECOTRIA) and bio-polyol (PO3G), while its Pharma segment sells Joins, Ginexin, and rivastigmine patches, and its subsidiary SK Bioscience runs vaccine, IV solution, and CDMO businesses. In 2025, consolidated revenue was KRW 2,365.2 billion, with segment shares of 65.6% for Green Chemicals Biz., 20.6% for the Pharma segment, and 27.6% for SK Bioscience, while exports accounted for 50.3% of revenue versus 49.7% domestic.

Products & technology

  • JoinsOsteoarthritis treatment (natural-derived drug)
  • GinexinBlood circulation improvement agent
  • Rivastigmine patchSynthetic pharmaceutical
  • SKYGREEN Copolyester resinCosmetic containers, electronic parts, construction materials
  • ECOZEN bio-based Copolyester resinElectronics, food containers, baby products
  • ECOTRIA recycled Copolyester resinCosmetic containers, packaging, household goods
  • Bio-polyol (PO3G)Bio-based material

Regulatory approvals

data.go.kr

150 Korean MFDS drug approvals · 1981–2026

  • MFDS drugVonosky Tab. 10mg (vonoprazan)2026-08-24
    Drug · Prescription · Approval202602455
  • MFDS drugVonosky Tab. 20mg (vonoprazan)2026-08-24
    Drug · Prescription · Approval202602456
  • MFDS drugSKYoneCAB Tablet 50mg(Tegoprazan)2026-08-11
    Drug · Prescription · Approval202602331
  • MFDS drugSKYoneCAB Tablet 25mg(Tegoprazan)2026-08-11
    Drug · Prescription · Approval202602332
  • MFDS drugEasyprafen Cap.2026-05-28
    Drug · Prescription · Approval202601558
  • MFDS drugCool night tab.2026-05-20
    Drug · OTC · Notification202601464
  • MFDS drugOmed Plus Tab. 10/300mg2026-05-13
    Drug · Prescription · Approval202601398
  • MFDS drugOmed Plus Tab. 20/600mg2026-05-13
    Drug · Prescription · Approval202601399
  • MFDS drugSilkyrea Cream(Urea)2026-04-07
    Drug · OTC · Notification202600967
  • MFDS drugScar Reborn Gel2026-01-28
    Drug · OTC · Notification202600242
  • MFDS drugTelamchlowTablet20/2.5/6.25mg2026-01-15
    Drug · Prescription · Approval202600129
  • MFDS drugNose-Bell Tab.2025-11-03
    Drug · OTC · Notification202502838
Show 68 more
  • MFDS drugTrast coin plaster2025-09-04
    Drug · OTC · Notification202502322
  • MFDS drugLacto Q Tab.2025-09-01
    Drug · OTC · Notification202502290
  • MFDS drugTrast Rubi Plaster2025-08-29
    Drug · OTC · Notification202502277
  • MFDS drugMeco Mag Plus Tab.2025-08-28
    Drug · OTC · Notification202502267
  • MFDS drugSokpyunhan Tab.2025-07-24
    Drug · OTC · Notification202501892
  • MFDS drugLidoprone Cream2025-07-14
    Drug · OTC · Notification202501780
  • MFDS drugCetirien Tab.2025-05-13
    Drug · OTC · Notification202501164
  • MFDS drugjangencle capsule2025-05-01
    Drug · OTC · Notification202501091
  • MFDS drugInvela Powder 0.8g(Sevelamer carbonate), Invela Powder 2.4g(Sevelamer carbonate),2025-04-15
    Drug · Prescription · Approval202500905
  • MFDS drugCocoN Cap.2025-04-11
    Drug · OTC · Notification202500864
  • MFDS drugGinexin Memocare Capsule2024-11-13
    Drug · OTC · Notification202402687
  • MFDS drugTryp-S Tab.2024-06-25
    Drug · OTC · Notification202401527
  • MFDS drugChondro-S 800 Tab.2024-06-20
    Drug · OTC · Notification202401489
  • MFDS drugDam en Cool Tab.2024-04-05
    Drug · OTC · Notification202400780
  • MFDS drugJoins-F Tab.2023-12-21
    Drug · Prescription · Approval202303397
  • MFDS drugToszet A Tablet 10/10/10mg(Ezetimibe, Atorvastatin Calcium Trihydrate, Amlodipine Besylate)2023-11-06
    Drug · Prescription · Approval202303069
  • MFDS drugToszet A Tablet 10/10/5mg(Ezetimibe, Atorvastatin Calcium Trihydrate, Amlodipine Besylate)2023-10-25
    Drug · Prescription · Approval202302979
  • MFDS drugSuvexx Tablet2023-08-01
    Drug · Prescription · Approval202302313
  • MFDS drugPower Join-S 600 Tab.2023-06-07
    Drug · OTC · Notification202301762
  • MFDS drugToszet A Tablet 10/40/10mg(Ezetimibe, Atorvastatin Calcium Trihydrate, Amlodipine Besylate)2023-05-31
    Drug · Prescription · Approval202301714
  • MFDS drugToszet A Tablet 10/20/10mg(Ezetimibe, Atorvastatin Calcium Trihydrate, Amlodipine Besylate)2023-05-31
    Drug · Prescription · Approval202301715
  • MFDS drugToszet A Tablet 10/20/5mg(Ezetimibe, Atorvastatin Calcium Trihydrate, Amlodipine Besylate)2023-05-31
    Drug · Prescription · Approval202301716
  • MFDS drugI-High Chewable Tab.Revoked2023-04-26
    Drug · OTC · Notification202301364
  • MFDS drugTeglutik oral suspension2022-05-31
    Drug · Prescription · Approval202202295
  • MFDS drugTrast Ibu Plaster(Ibuprofen)2022-03-29
    Drug · OTC · Notification202201233
  • MFDS drugRemitch OD Tablet 2.5μg(Nalfurafine HCl)2021-10-26
    Drug · Prescription · Approval202107133
  • MFDS drugCosca Tablet 25mg(Losartan Potassium)2021-04-13
    Drug · Prescription · Approval202103090
  • MFDS drugToszet Tablet 10/20mg2021-01-08
    Drug · Prescription · Approval202100237
  • MFDS drugToszet Tablet 10/10mg2021-01-08
    Drug · Prescription · Approval202100238
  • MFDS drugToszet Tablet 10/40mg2021-01-08
    Drug · Prescription · Approval202100239
  • MFDS drugGinexin-F Tablet 240mg(Ginkgo leaf dry extract)2020-12-24
    Drug · OTC · Approval202009212
  • MFDS drugTrast Plaster(Piroxicam)2020-12-01
    Drug · OTC · Notification202008405
  • MFDS drugLaton PR Tablet 2mg(Melatonin)2020-09-22
    Drug · Prescription · Approval202006549
  • MFDS drugTocinib Tablet 5mg(Tofacitinib)2020-09-07
    Drug · Prescription · Approval202006210
  • MFDS drugTrast Felbin Plaster(Felbinac)Revoked2020-07-07
    Drug · OTC · Notification202004913
  • MFDS drugTrast Finger Plaster(Ketoprofen)2020-04-22
    Drug · OTC · Notification202002866
  • MFDS drugTrast Difen Plaster(Diclofenac)2020-04-21
    Drug · OTC · Notification202002817
  • MFDS drugRenexin CR Tablet2020-03-24
    Drug · Prescription · Approval202002062
  • MFDS drugOngentys Capsule 50mg(Opicapone)2019-11-26
    Drug · Prescription · Approval201908093
  • MFDS drugOngentys Capsule 25mg(Opicapone)2019-11-26
    Drug · Prescription · Approval201908094
  • MFDS drugNewdotop Cataplasma(Lidocaine)2019-11-18
    Drug · Prescription · Notification201907969
  • MFDS drugRomelain Enteric Coated Tablet (Bromelain)2019-11-12
    Drug · OTC · Notification201907883
  • MFDS drugMupisphen TabletRevoked2019-09-06
    Drug · OTC · Notification201906343
  • MFDS drugVimsk Injection(Lacosamide)2019-03-29
    Drug · Prescription · Approval201901941
  • MFDS drugSumediphen 8 hours ER Tablet 650mg(Acetaminophen)Revoked2018-12-24
    Drug · OTC · Approval201805241
  • MFDS drugGinexin-F Tablet 120mg(Ginkgo leaf dry extract)2018-10-30
    Drug · OTC · Notification201804292
  • MFDS drugCosca EX Tablet 10/50mg2018-06-12
    Drug · Prescription · Approval201802434
  • MFDS drugCosca EX Tablet 5/100mg2018-06-12
    Drug · Prescription · Approval201802435
  • MFDS drugCosca EX Tablet 5/50mg2018-06-12
    Drug · Prescription · Approval201802436
  • MFDS drugCaremixin Plus Ointment2018-05-11
    Drug · OTC · Notification201802006
  • MFDS drugSrtec Soft Capsule 10mg(Cetirizine HCl)Revoked2018-01-09
    Drug · OTC · Notification201800131
  • MFDS drugQudexy XR Capsule 100mg(Topiramate)2017-08-08
    Drug · Prescription · Approval201706471
  • MFDS drugQudexy XR Capsule 200mg(Topiramate)2017-08-08
    Drug · Prescription · Approval201706472
  • MFDS drugQudexy XR Capsule 25mg(Topiramate)2017-08-08
    Drug · Prescription · Approval201706473
  • MFDS drugQudexy XR Capsule 50mg(Topiramate)2017-08-08
    Drug · Prescription · Approval201706474
  • MFDS drugDoublezyme Tablet2016-10-13
    Drug · OTC · Notification201606067
  • MFDS drugVimsk Tablet 150mg(Lacosamide)2016-08-31
    Drug · Prescription · Approval201605341
  • MFDS drugVimsk Tablet 200mg(Lacosamide)2016-08-31
    Drug · Prescription · Approval201605342
  • MFDS drugVimsk Tablet 50mg(Lacosamide)2016-08-31
    Drug · Prescription · Approval201605343
  • MFDS drugVimsk Tablet 100mg(Lacosamide)2016-08-31
    Drug · Prescription · Approval201605344
  • MFDS drugSK Rivaroxaban Tablet 2.5mgRevoked2016-07-06
    Drug · Prescription · Approval201604177
  • MFDS drugSkad B Tablet(Amlodopine Besylate)2016-06-10
    Drug · Prescription · Approval201603342
  • MFDS drugNebido, Solution for injection 250 mg per 1ml2015-12-17
    Drug · Prescription · Approval201508309
  • MFDS drugExonin CR Tablet(Eperisone HCl)2015-03-31
    Drug · Prescription · Approval201501694
  • MFDS drugInvela Tablet(Sevelamer carbonate)2015-03-31
    Drug · Prescription · Approval201501773
  • MFDS drugAnpla X SR Tablet 300mg(Sarpogrelate HCl)2015-01-23
    Drug · Prescription · Approval201500371
  • MFDS drugNapmed Tablet 500/20mg2014-07-10
    Drug · Prescription · Approval201403085
  • MFDS drugWondron Patch 10(Rivastigmine)2014-03-31
    Drug · Prescription · Approval201401524

Showing the 80 most recent of 150 records.

Clinical trials

data.go.kr

59 MFDS clinical trial authorisations · 2012–2025 (Phase 1 19 · Phase 3 19 · Bioequivalence 15 · Phase 2 4 · Phase 1/2 2)

  • Phase 1SID25012025-12-03

    2 trial sites

  • Phase 1SID24052025-10-28

    1 trial site

  • Phase 3SID24062025-05-30

    1 trial site

  • Phase 1AD-1202025-03-17

    2 trial sites

  • BioequivalenceMSF1002024-08-08

    1 trial site

  • BioequivalenceSID21022024-06-12

    2 trial sites

  • BioequivalenceSID21022023-10-26

    2 trial sites

  • BioequivalenceSID21012023-05-22

    1 trial site

  • Phase 3SKO_22012022-11-24

    1 trial site

  • Phase 1SID19032022-06-02

    2 trial sites

  • Phase 1SID19032021-09-29

    2 trial sites

  • BioequivalenceSID19012021-06-09

    2 trial sites

Show 47 more
  • Phase 3SKCPT2020-11-30

    14 trial sites

  • Phase 1QDX2020-05-08

    1 trial site

  • Bioequivalence코스카정100밀리그램(로사르탄칼륨)2016-08-31

    2 trial sites

  • Phase 3SID1422016-08-05

    19 trial sites

  • Phase 1SID1422016-05-16

    1 trial site

  • Phase 3SK-NBP6082016-03-07

    15 trial sites

  • Phase 3SK-NBP6082016-03-07

    1 trial site

  • Phase 1NBP621/6192016-02-12

    1 trial site

  • Phase 1/2SK-NBP613경구용약독화로타생바이러스백신(사람-소재배열)2015-11-18

    5 trial sites

  • Bioequivalence미가드정2.5mg(프로바트립탄숙신산염일수화물)2015-08-18

    2 trial sites

  • Phase 3SK-NBP6082015-07-30

    8 trial sites

  • Phase 1SID1422015-06-04

    1 trial site

  • Bioequivalence에스케이리바록사반정2.5밀리그램(리바록사반)2015-01-08

    2 trial sites

  • Bioequivalence에스케이리바록사반정20밀리그램(리바록사반)2015-01-05

    2 trial sites

  • BioequivalenceSID1252014-11-17

    2 trial sites

  • Phase 3THVD-2012014-11-10

    16 trial sites

  • Phase 3SK-NBP607QIV세포배양인플루엔자백신주-4가2014-09-29

    8 trial sites

  • Phase 3SK-NBP607QIV세포배양인플루엔자백신주-4가2014-09-29

    10 trial sites

  • Phase 3CPT302014-08-07

    13 trial sites

  • Phase 1SID1232014-08-06

    1 trial site

  • Phase 2SID1232014-05-20

    10 trial sites

  • Phase 3폐렴구균-단백접합백신주(NBP606)(정제폐렴구균다당류-디프테리아CRM197단백질접합체) 13가2014-05-16

    13 trial sites

  • Phase 1SK-NBP613경구용약독화로타생바이러스백신(사람-소재배열)2014-03-21

    1 trial site

  • Phase 1SK-NBP615인유두종바이러스백신주-4가2014-03-07

    1 trial site

  • Phase 1/2SK-NBP607QIV세포배양인플루엔자백신주-4가2014-02-06

    1 trial site

  • Phase 1SKI26702014-02-05

    6 trial sites

  • Phase 1CPT302013-12-24

    1 trial site

  • Phase 3폐렴구균-단백접합백신주(NBP606)(정제폐렴구균다당류-디프테리아CRM197단백질접합체) 13가2013-11-21

    15 trial sites

  • Phase 3SK-NBP6082013-11-07

    6 trial sites

  • Phase 3폐렴구균-단백접합백신주(NBP606)(정제폐렴구균다당류-디프테리아CRM197단백질접합체) 13가2013-11-05

    12 trial sites

  • Bioequivalence에스케이코스카플러스에프정2013-10-14

    2 trial sites

  • Phase 2YKP108112013-10-01

    19 trial sites

  • Phase 2CPT302013-09-26

    6 trial sites

  • Bioequivalence에스케이리바스티그민패취15(리바스티그민)2013-09-02

    2 trial sites

  • Phase 1SID1232013-09-02

    1 trial site

  • Phase 3세포배양인플루엔자백신주2013-08-23

    10 trial sites

  • Phase 3세포배양인플루엔자백신주2013-08-23

    7 trial sites

  • Bioequivalence엠빅스에스구강붕해필름50밀리그램(미로데나필)2013-08-12

    1 trial site

  • Phase 1CPT302013-04-23

    1 trial site

  • Bioequivalence에스케이리바스티그민패취10(리바스티그민)2013-02-01

    2 trial sites

  • Phase 3폐렴구균-단백접합백신주(NBP606)(정제폐렴구균다당류-디프테리아CRM197단백질접합체) 13가2012-10-25

    15 trial sites

  • Phase 1SK-NBP6082012-09-03

    1 trial site

  • Phase 1세포배양인플루엔자백신주2012-07-31

    10 trial sites

  • Phase 3SOTB072012-07-09

    22 trial sites

  • Phase 2SKI32462012-07-09

    17 trial sites

  • Bioequivalence프로맥정75밀리그램(폴라프레징크)2012-06-18
  • Phase 1페브릭정40mg(페북소스타트) (TMX-67)2012-01-02

    1 trial site

AI reads

MAA server logs · IP-verified
0
Read to answer a question

Someone asked an AI a question, and it fetched this page live to answer.

6
Crawled for indexing

Collected for later use. Not a signal of interest.

0answer
index 6
Last 7 days
0answer
index 6
Last 30 days
0answer
index 6
All time
  • OpenAIOAI-SearchBot6

Measured since Aug 25, 2026 · 1 AI engines · last read Aug 26, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS.

Connect this index to your AI tool →

Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies approved for the same productsBiotech & Drug Discovery

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

SK Bioscience Co.,Ltd1 shared

A vaccine specialist developing in-house products such as SKYCellflu and SKYZoster while also serving as CDMO for AstraZeneca and Novavax.

AHNLAB,INC.100

KOSDAQ-listed integrated security company behind the V3 antivirus and AhnLab TrusGuard and XDR solutions.

ORGANOIDSCIENCES LTD.100

Organoid-based biotech founded 2018, KOSDAQ-listed 2025, developing the ATORM-C regenerative therapeutic and ODISEI evaluation solution.

CG Invites Co., Ltd.85

Genomics and drug developer behind the osteoarthritis drug Acelex and the AI-driven healthcare platform Invites Loop.

Eone Diagnomics Genome Center Co., Ltd.85

EDGC, a Korea-US joint venture of Eone Medical Foundation and Diagnomics, offers the NIPT service NICE and liquid biopsy OncoCatch.

ABION Inc.85

KOSDAQ-listed biotech developing biomarker-driven targeted cancer therapies including lead candidate Vabametkib (ABN401).

Y-Biologics, Inc85

KOSDAQ-listed antibody biotech developing the next-generation immuno-oncology candidate Multi-AbKine on its fully human antibody library Ymax®-ABL.

ProGen, Co,, LTD.85

KONEX-listed biotech venture developing new drug candidates with its multi-target fusion protein platform NTIG®

GI Innovation Inc.85

Biotech company developing fusion-protein immuno-oncology and allergy therapeutics, listed on KOSDAQ since 2023.

SillaJen, Inc.85

SillaJen, Inc., founded in 2006 and listed on KOSDAQ in 2016, develops the oncolytic virus immunotherapy Pexa-Vec.

LigaChem Biosciences Inc.83

An ADC (antibody-drug conjugate) developer with its ConjuALL platform, having licensed pipeline assets to Janssen, Ono Pharmaceutical, and other global partners.

Cellid Co., Ltd.75

KOSDAQ-listed biopharma developing the BVAC cancer immunotherapy vaccine series and the AdCLD-CoV19-1 COVID-19 vaccine.

Sources and updates

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
AI visibility
Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition